StonvexLoading…
StonvexStonvexStonvexCore line items from TBTC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.05M | $11.16M | $9.49M | $11.06M |
Operating Income | $1.60M | $1.72M | $1.68M | $2.02M |
Net Income | $1.63M | $1.58M | $1.61M | $1.62M |
EPS (Diluted) | $0.35 | $0.34 | $0.35 | $0.35 |
Total Assets | $14.37M | $13.52M | $11.74M | $10.67M |
Total Liabilities | $1.52M | $2.06M | $1.84M | $2.40M |
Cash & Equivalents | $8.24M | $2.26M | $3.49M | $4.79M |
Free Cash Flow OCF − CapEx | $1.78M | $1.89M | $355.52K | $-63.88K |
Shares Outstanding | 4.64M | 4.64M | 4.63M | 4.62M |